NCT07920198 Adrenal Diseases in the Population of Modena: A Clinical-Epidemiological Database of Patients Referred to the Adrenal Disorders Outpatient Clinic of the Clinical Unit of Endocrinology at the Modena University Hospital (AOU Modena)
| NCT ID | NCT07920198 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Azienda Ospedaliero-Universitaria di Modena |
| Condition | Cushing s Syndrome |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,000 participants |
| Start Date | 2026-07-09 |
| Primary Completion | 2030-02-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,000 participants in total. It began in 2026-07-09 with a primary completion date of 2030-02-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Primary Objective: The primary objective of the study is to characterize subjects affected by adrenal disease by collecting medical history data at diagnosis, clinical, bio-humoral, and radiological data, as well as information regarding the therapeutic approach, in terms of both potential surgical interventions and/or pharmacological therapies and hormone replacement therapies. Secondary Objective: The secondary objective is to integrate these data with current knowledge in order to improve the clinical, diagnostic, and therapeutic management of patients affected by adrenal disease, as well as to identify risk and/or predisposing factors for the development of the disease. Study Design: Observational, longitudinal, single-center, non-interventional (without drug administration) study. The study is divided into two phases: FIRST PHASE (retrospective): registration of all patients affected by hypothalamic-pituitary-adrenal disease followed by the Adrenal Diseases Outpatient Clinic of the Endocrinology Unit at the AOU of Modena. SECOND PHASE (prospective): enrollment of all patients affected by adrenal disease consecutively presenting to the Adrenal Diseases Outpatient Clinic of the Endocrinology Unit at the AOU of Modena. Study Population Inclusion criteria: subjects affected by adrenal disease presenting to the Adrenal Diseases Outpatient Clinic of the Endocrinology Unit at the AOU of Modena, who are able to autonomously provide written informed consent. Exclusion criteria: subjects under 18 years of age. Study Methodologies An anonymized database will be created to collect data from patients presenting to the aforementioned outpatient clinic. Specifically, the data collected for each patient will include: demographic data, data related to the adrenal disease, symptoms, physical examination, radiological imaging, surgical intervention data, histological examination data, bio-humoral tests, hormonal tests, DEXA data, current replacement therapies data, current anti-secretory medical therapies data, data on other current pharmacological therapies, and comorbidities data.
Eligibility Criteria
Inclusion Criteria: * Subjects affected by adrenal disease presenting to the Adrenal Diseases Outpatient Clinic of the Endocrinology Unit at the AOU of Modena, who are able to autonomously provide written informed consent Exclusion Criteria: * none
Frequently Asked Questions
Who can join the NCT07920198 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Cushing s Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07920198 currently recruiting?
Yes, NCT07920198 is actively recruiting participants. Visit ClinicalTrials.gov or contact Azienda Ospedaliero-Universitaria di Modena to inquire about joining.
Where is the NCT07920198 trial being conducted?
This trial is being conducted at Modena, Italy.
Who is sponsoring the NCT07920198 clinical trial?
NCT07920198 is sponsored by Azienda Ospedaliero-Universitaria di Modena. The trial plans to enroll 2,000 participants.